5,625 research outputs found
Comparison of SEER Treatment Data With Medicare Claims
The population-based Surveillance, Epidemiology, and End Results (SEER) registries collect information on first-course treatment, including surgery, chemotherapy, radiation therapy, and hormone therapy. However, the SEER program does not release data on chemotherapy or hormone therapy due to uncertainties regarding data completeness. Activities are ongoing to investigate the opportunity to supplement SEER treatment data with other data sources
Reduced risk of synovial sarcoma in females: X-chromosome inactivation?
Synovial sarcoma shows a characteristic t(X;18) translocation but not the expected female predominance in incidence. We speculate that, among females, one X-chromosome is inactivated and that only the translocation to an active X-chromosome leads to development of synovial sarcoma. Population-based cancer registry data from the SEER program support this hypothesis
2010 Cancer in Iowa Report, 2010
Cancer is a reportable disease as stated in the Iowa Administrative Code. Cancer data are collected by the State Health Registry of Iowa, located at The University of
Iowa in the College of Public Health’s Department of Epidemiology. The staff includes more than 50 people. Half of them, situated throughout the state, regularly visit hospitals, clinics, and medical laboratories in Iowa and neighboring states to collect cancer data. A follow-up
program tracks more than 99 percent of the cancer survivors diagnosed since 1973. This program provides regular updates
for follow-up and survival. The Registry maintains the confidentiality of the patients, physicians, and hospitals providing data. In 2010 data will be collected on an
estimated 16,400 new cancers among Iowa residents. In situ cases of bladder cancer are included in the estimates for bladder cancer, to be in agreement with the definition of reportable cases of the Surveillance, Epidemiology, and End
Results (SEER) Program of the National Cancer Institute.
Since 1973 the Iowa Registry has been funded by the SEER Program of the National Cancer Institute. Iowa represents
rural and Midwestern populations and provides data included in many NCI publications. Beginning in 1990 about 5-10
percent of the Registry’s annual operating budget has been provided by the state of Iowa. Beginning in 2003, the University of Iowa has also been providing cost-sharing
funds. The Registry also receives funding through grants and contracts with university, state, and national researchers investigating cancer-related topics
2012 Cancer in Iowa Report: A Focus on Lung Cancer, 2012
Cancer is a reportable disease as stated in the Iowa Administrative Code. Cancer data are collected by the State Health Registry of Iowa, located at The University of Iowa in the College of Public Health’s Department of epidemiology. The staff includes more than 50 people.
Half of them, situated throughout the state, regularly visit hospitals, clinics, and medical laboratories in Iowa
and neighboring states to collect cancer data. A follow-up program tracks more than 99 percent of the cancer
survivors diagnosed since 1973. This program provides regular updates for follow-up and survival. The Registry
maintains the confidentiality of the patients, physicians, and hospitals providing data. In 2012 data will be collected
on a projected 17,500 new cancers among Iowa residents. In situ cases of bladder cancer are included in the
projections for bladder cancer, to be in agreement with the definition of reportable cases of the Surveillance,
Epidemiology, and End Results (SEER) Program of the NCI.
Since 1973 the Iowa Registry has been funded by the SEER Program of the NCI. Iowa represents rural and Midwestern populations and provides data included in many NCI publications. Beginning in 1990 about 5-10 percent
of the Registry’s annual operating budget has been provided by the state of Iowa. Beginning in 2003, the University of Iowa has also been providing cost-sharing funds. The
Registry also receives funding through grants and contracts with university, state, and national researchers
investigating cancer-related topics
2008 Cancer in Iowa Report, 2008
Cancer is a reportable disease as stated in the Iowa Administrative Code. Cancer data are collected by the State Health Registry of Iowa, located at The University of Iowa in the College of Public Health’s Department of Epidemiology. The staff includes more than 50 people. Half of them, situated throughout the state, regularly visit hospitals, clinics, and medical laboratories in Iowa
and neighboring states to collect cancer data. A follow-up program tracks more than 99 percent of the cancer survivors diagnosed since 1973. This program provides regular updates for followup and survival. The Registry maintains the confidentiality of the patients, physicians, and hospitals providing data. In 2008 data will be collected on an estimated 16,000 new cancers among Iowa residents. Noninvasive cases of bladder cancer are included in the estimates for bladder cancer, to be in agreement
with the definition of reportable cases of the Surveillance,
Epidemiology, and End Results (SEER) Program of the National
Cancer Institute. Since 1973 the Iowa Registry has been funded primarily by the SEER Program of the National Cancer Institute. Iowa represents rural and Midwestern populations and provides data included in many National Cancer Institute publications. Beginning in 1990 a small percent of the Registry’s annual operating budget has been provided by the state of Iowa. Beginning in 2003, the University of Iowa has also been providing cost-sharing funds.
The Registry also receives funding through grants and contracts with university, state, and national researchers investigating cancer-related topics
2014 Cancer in Iowa Report, 2014
Cancer is a reportable disease as stated in the Iowa
Administrative Code. Cancer data are collected by the State Health Registry of Iowa, located at The University of Iowa in the College of Public Health’s Department of Epidemiology. The staff includes more than 50 people. Half of them, situated throughout the state, regularly visit hospitals, clinics, and medical laboratories in Iowa and neighboring states to collect cancer data. A follow-up program tracks more than 99 percent of the cancer survivors diagnosed since 1973. This program provides regular updates for follow-up and survival. The Registry maintains the confidentiality of the patients, physicians, and hospitals providing data. In 2014 data will be collected on an estimated 17,400 new cancers among Iowa residents. In situ cases of bladder cancer are included in the estimates for bladder cancer, to be in agreement with the definition of reportable cases of the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute.
Since 1973 the Iowa Registry has been funded by the
SEER Program of the National Cancer Institute. Iowa
represents rural and Midwestern populations and provides
data included in many NCI publications. Beginning in 1990
about 5-10 percent of the Registry’s annual operating
budget has been provided by the state of Iowa. Beginning
in 2003, the University of Iowa has also been providing
cost-sharing funds. The Registry also receives funding
through grants and contracts with university, state, and
national researchers investigating cancer-related topics
2007 Cancer in Iowa Report, 2007
Cancer is a reportable disease as stated in the Iowa Administrative Code. Cancer data are collected by the State Health Registry of Iowa, located at The University of Iowa in the College of Public Health’s Department of
Epidemiology. The staff includes more than 50 people. Half of them, situated throughout the state, regularly visit hospitals, clinics, and medical laboratories in Iowa and neighboring states to collect cancer data. A follow-up program tracks more than 99 percent of the cancer survivors diagnosed since 1973. This program provides regular updates for follow-up and survival. The Registry maintains the
confidentiality of the patients, physicians, and hospitals providing data. In 2007 data will be collected on an estimated 15,700 new cancers among Iowa residents. In situ cases of bladder cancer are included in the estimates for
bladder cancer, to be in agreement with the definition of reportable cases of the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute.
Since 1973 the Iowa Registry has been funded by the SEER Program of the National Cancer Institute. Iowa represents rural and Midwestern populations and provides data included in many NCI publications. Beginning in 1990 about 5-10 percent of the Registry’s annual operating budget has been provided by the state of Iowa. Beginning in 2003, the University of Iowa has also been providing cost-sharing funds. In addition, the Registry receives funding through grants and contracts with university, state, and national researchers investigating cancer-related topics
2009 Cancer in Iowa Report: Data Sources, 2009
Cancer is a reportable disease as stated in the Iowa Administrative Code. Cancer data are collected by the State Health Registry of Iowa, located at The University of Iowa in the College of Public Health’s Department of Epidemiology. The staff includes more than 50 people. Half of them, situated throughout the state, regularly visit hospitals, clinics, and medical laboratories in Iowa and neighboring states to collect cancer data. A follow-up program tracks more than 99 percent of the cancer survivors diagnosed since 1973. This program provides regular updates for follow-up and survival. The Registry maintains the confidentiality of the patients, physicians, and hospitals providing data. In 2009 data will be collected on an estimated 16,000 new cancers among Iowa residents. In situ cases of bladder cancer are included in the estimates for bladder cancer, to be in agreement with the definition of reportable cases of the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute.
Since 1973 the Iowa Registry has been funded primarily
by the SEER Program of the National Cancer Institute.
Iowa represents rural and Midwestern populations and
provides data included in many National Cancer Institute
publications. Beginning in 1990 between 5 and 10 percent
of the Registry’s annual operating budget has been provided
by the state of Iowa. Beginning in 2003, the University
of Iowa has been providing cost-sharing funds. The Registry
also receives funding through grants and contracts with
university, state, and national researchers investigating
cancer-related topics
2013 Cancer in Iowa Report, 2013
Cancer is a reportable disease as stated in the
Iowa Administrative Code. Cancer data are collected by the State Health Registry of Iowa, located at The University of Iowa in the College of Public Health’s Department of Epidemiology. The staff includes more than 50 people. Half of them, situated throughout the state, regularly visit hospitals, clinics, and medical laboratories in Iowa and neighbor-ing states to collect cancer data. Hospital cancer programs approved by the American College of Surgeons also report their data. A follow-up program tracks more than 99 percent of the cancer survivors diagnosed since 1973. This program provides regular updates for follow-up and survival. The Registry maintains the confidentiality of the patients, physicians, and hospitals providing data.
In 2013 data will be collected on an estimated 17,300 new cancers among Iowa residents. In situ cases of bladder cancer are included in the estimates for bladder cancer, to be in agreement with the definition of reportable cases of the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. Since 1973 the Iowa Registry has been funded by the SEER Program of the National Cancer Institute. Iowa represents rural and Midwestern populations and provides data included in many NCI publications. Beginning in 1990 about 5-10 percent of the Registry’s annual operating budget has been provided by the state of Iowa. Starting in 2003, the University of Iowa has also been providing cost-sharing funds. In addition the Registry receives funding through grants and contracts with university, state, and national researchers investigating cancer-related topics
- …